Some investors are considering whether BioMarin Pharmaceutical's current share price reflects its underlying value, or if the market may be overlooking certain factors. The stock last closed at US$54.
3d
BioMarin Pharmaceutical's Rare Disease Portfolio Supplemented By Amicus Acquisition Makes It A Buy
This is my fourth BioMarin article following 01/2025's "BioMarin Pharmaceuticals: Share Downdraft Combined With VOXZOGO ...
Detailed price information for Biomarin Pharmaceuticals (BMRN-Q) from The Globe and Mail including charting and trades.
A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports ...
We recently compiled a list of the 10 Quality Value Stocks Likely to Make a Comeback According to Analysts. BioMarin Pharmaceutical Inc. is among the best value stocks to invest in. TheFly reported on ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
World Hemophilia Day spotlights the rare blood disorder that prevents the blood from clotting and can be dangerous when left ...
Against a backdrop of geopolitical conflict in the Gulf and rising investments in AI, retail investors increased their ...
Opinion
1dOpinion
World Federation of Hemophilia: World Hemophilia Day 2026 - April 17, 2026 - "Diagnosis: First step to care."
On April 17, 2026, the global inherited bleeding disorders community will come together on World Hemophilia Day to advocate for all inherited bleeding ...
President Donald Trump has signed an executive order imposing tariffs of up to 100% on imported brandname medicines, unless manufacturers sign up for drug pricing deals or set up facilities to make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results